首页
订购/客服:400-666-5481

Nicodicosapent

    
≥98%

Nicodicosapent

源叶(MedMol)
S82674 一键复制产品信息
1269181-69-2
C28H39N3O2
449.6282
N-(2-(5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenamidoethyl)nicotinamide; N-(2-(5Z,8Z,11Z,14Z,17Z)icosa-5,8,11,14,17-pentaenamidoethyl)nicotinamide;
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S82674-5mg
≥98%

¥1490.00

货期:3-5天 - - - -
S82674-10mg
≥98%

¥2690.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
靶点: Fatty Acid Synthase (FASN);Autophagy;Others
体外研究: Nicodicosapent decreases the production of mature SREBP-2 protein in HepG2 cells, but does not interact with the GPR109A receptor. Nicodicosapent shows a synergistic inhibition on secreted PCSK9 and has an IC50 value of 17 μM. Nicodicosapent significantly inhibits ApoB secretion in a dose-dependent manner with IC50 of 27 μM. Nicodicosapent results in a time-dependent hydrolysis in HepG2 cells
体内研究: Nicodicosapent (100 mg/kg po) produces high plasma levels of nicotinuric acid in the plasma. ApoE*3-Leiden mice treated with Nicodicosapent show a significant reduction in PCSK9 levels, LDL particles including VLDL and LDL cholesterol, as well as plasma triglycerides
参考文献: 1. Vu CB, et al. Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid. J Med Chem. 2016 Feb 11;59(3):1217-31.
溶解性: Soluble  in  DMSO、Ethanol
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.224 ml 11.12 ml 22.241 ml
5 mM 0.445 ml 2.224 ml 4.448 ml
10 mM 0.222 ml 1.112 ml 2.224 ml
50 mM 0.044 ml 0.222 ml 0.445 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×